Fifty years of progressive supranuclear palsy (Q38135221)

29 August 2017

title

Fifty years of progressive supranuclear palsy (English)

1 reference

29 August 2017

Matteo Bologna

3

0 references

Alfredo Berardelli

object named as

Alfredo Berardelli

series ordinal

4

0 references

Carlo Colosimo

series ordinal

1

object named as

Carlo Colosimo

1 reference

29 August 2017

Thomas H Bak

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

6 September 2013

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

29 August 2017

published in

1 reference

29 August 2017

volume

85

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

938-944

1 reference

J. Clifford Richardson and 50 years of progressive supranuclear palsy

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Presymptomatic Hypertension Is a Major Feature in the Diagnosis of Progressive Supranuclear Palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Progressive supranuclear palsy syndrome induced by clebopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Emotion recognition in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Does corticobasal degeneration exist? A clinicopathological re-evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Criteria for the diagnosis of corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Visuospatial functions in atypical parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

The ALS/PDC syndrome of Guam and the cycad hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Accuracy of clinical diagnosis of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

A clinical rating scale for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Tau exon 10 16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Substructure of 20 nm filaments of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

The `subcortical dementia' of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

The relationship between clinical and pathological variables in Richardson's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Tau pathology and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Study of the rostral midbrain atrophy in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

New and reliable MRI diagnosis for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Transcranial magnetic stimulation for differential diagnostics in patients with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Abnormal cortical synaptic plasticity in primary motor area in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Donepezil in the treatment of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Clinical value of botulinum toxin in neurological indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JNNP-2013-305740

21 January 2018

Identifiers

DOI

10.1136/JNNP-2013-305740

1 reference

29 August 2017

1 reference